Kenvue includes Johnson & Johnson brands Tylenol, Listerine, Neutrogena and Nicorette in its portfolio. The financial terms of the transaction were not disclosed; however, proceeds from the sale will go to Johnson & Johnson.
The company had a net income of $1.7 billion for the nine-month period ending Oct. 2.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
